Moira Dunne

GlaxoSmithKline (United Kingdom)

Papers

2

Total Citations

38

H-Index

2

About

Moira Dunne is a pioneering analytical chemist whose work has advanced the precision and automation of bioanalytical methods for pharmaceutical compounds. Her research focuses on developing robust, fully automated assays that integrate solid-phase extraction with high-performance liquid chromatography (HPLC) to quantify drugs in biological matrices. Her most cited paper, a 1996 study on sumatriptan in human serum, achieved 35 citations and demonstrated a groundbreaking method using electrochemical detection to achieve high sensitivity and reproducibility. This work, alongside her earlier 1994 assay for GR117289X in human plasma, showcases her expertise in optimizing mixed-mode solid-phase extraction and ultraviolet detection for complex biological samples. Dunne’s contributions have streamlined drug monitoring in clinical and pharmacokinetic studies, reducing manual error and enhancing throughput. Her automated approaches remain foundational for researchers seeking efficient, reliable quantification of therapeutic agents, underscoring her lasting impact on bioanalytical chemistry and pharmaceutical development.

Research Focus

Key Achievements

2
H-Index
2
Papers
38
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Fully automated assay for the determination of sumatriptan in human serum using solid-phase extraction and high-performance liquid chromatography with electrochemical detection
35 citations · 1996
📈 Most Prolific Year: 1996 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: GlaxoSmithKline (United Kingdom)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago